Belviq 10 mg (Lorcaserin) Tablets – Alphahealthmart
-9%

Belviq 10 mg (Lorcaserin) Tablets – Alphahealthmart

$295.99 Sales Tax

Belviq 10 mg (Lorcaserin) Tablets

Belviq is used to help adults who are obese or who are overweight and have weight-related medical problems to lose weight and keep from gaining back that weight.

Belviq 10 mg

$295.99 Sales Tax

Add to cart
Buy Now

What is Belviq?

Belviq 10 mg is used to help adults who are obese or who are overweight and have weight-related medical problems to lose weight and keep from gaining back that weight. This medecine must be used along with a reduced calorie diet and an exercise plan. It is in a class of medications called serotonin receptor agonists. It works by increasing feelings of fullness so that less food is eaten.

How belviq 10 mg Works

Belviq is  FDA-approved for use in adults with a BMI of 30 and over, or for people who have a body mass index of at least 27 and have at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol.

It is designed to help you feel full after you’ve eaten less food. The medication activates serotonin receptors in your brain. The serotonin receptors regulate hunger. When they signal your body to feel full, you may be able to eat less and lose weight.

Prescribing information for Belviq explains that users take one 10 milligram pill twice each day along with a low-calorie diet and exercise program. According to the FDA, the drug should be taken for the rest of the patient’s life to maintain a healthy weight. Belviq should not be taken by women who are pregnant or breastfeeding.

Side effects Belviq

Common side effects of this medecine include the following:

In non-diabetic patients:

headache
dizziness
fatigue
nausea
dry mouth
constipation
In Diabetic patients:

low blood sugar (hypoglycemia)
headache
back pain
cough
fatigue
This is not a complete list of this medecine side effects.

Interactions

Caution with concomitant triptans, MAOIs, linezolid, SSRIs, SNRIs, TCAs, bupropion, lithium, tramadol, tryptophan, St. John’s wort, antipsychotics, dopamine antagonists, or PDE-5 inhibitors. Potentiates dextromethorphan and other CYP2D6 substrates. Increased risk of cardiac valvulopathy with concomitant drugs that are potent 5-HT2B receptor agonists (eg, cabergoline). Concomitant insulin: not studied. Other medicines like Regenon Retard can help also.

Browse More Products